{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:47:27Z","timestamp":1772675247354,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cyto.2018.04.026","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T11:48:54Z","timestamp":1524656934000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barr\u00e9 Syndrome"],"prefix":"10.1016","volume":"110","author":[{"given":"Monojit","family":"Debnath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Nagappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinku Mani","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Subbanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sundaravadivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkataram","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debprasad","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Wahatule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjib","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parayil Sankaran","family":"Bindu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Periyavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Umamaheswara Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun B.","family":"Taly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 9","key":"10.1016\/j.cyto.2018.04.026_b0005","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"issue":"Suppl","key":"10.1016\/j.cyto.2018.04.026_b0010","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol"},{"issue":"5","key":"10.1016\/j.cyto.2018.04.026_b0015","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI113231","article-title":"Activation of terminal components of complement in patients with Guillain-Barre syndrome and other demyelinating neuropathies","volume":"80","author":"Koski","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2018.04.026_b0020","doi-asserted-by":"crossref","first-page":"740947","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.cyto.2018.04.026_b0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.04.026_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2017.10.003","article-title":"Associations between tumor necrosis factor-alpha gene polymorphisms and the risk of Guillain-Barre syndrome and its subtypes: a systematic review and meta-analysis","volume":"313","author":"Liu","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.cyto.2018.04.026_b0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-510X(97)00178-0","article-title":"T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome","volume":"153","author":"Dahle","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2018.04.026_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1468-1331.1996.tb00428.x","article-title":"Dynamics of mRNA expression of interferon-gamma, interleukin 4 and transforming growth factor beta1 in sciatic nerves and lymphoid organs in experimental allergic neuritis","volume":"3","author":"Zhu","year":"1996","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"6","key":"10.1016\/j.cyto.2018.04.026_b0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1526-0968.2001.00386.x","article-title":"Plasmapheresis affects T helper type-1\/T helper type-2 balance of circulating peripheral lymphocytes","volume":"5","author":"Goto","year":"2001","journal-title":"Ther. Apher."},{"issue":"Suppl","key":"10.1016\/j.cyto.2018.04.026_b0060","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.cyto.2018.04.026_b0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J. Neurol. Neurosurg. Psych."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2018.04.026_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-5728(98)00053-8","article-title":"Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha\/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage","volume":"87","author":"Hohnoki","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2018.04.026_b0080","doi-asserted-by":"crossref","first-page":"639712","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome","volume":"2013","author":"Li","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.cyto.2018.04.026_b0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/clin.1998.4573","article-title":"Recovery from Guillain-Barre syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma","volume":"88","author":"Elkarim","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cyto.2018.04.026_b0090","doi-asserted-by":"crossref","first-page":"260473","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2018.04.026_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(00)00388-X","article-title":"IL-10 and IFN-gamma in Guillain-Barre syndrome. Network Members of the Swedish Epidemiological Study Group","volume":"112","author":"Press","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.04.026_b0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jnnp.64.2.162","article-title":"Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function","volume":"64","author":"Creange","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.cyto.2018.04.026_b0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.icb.7100114","article-title":"Autoimmunity: IL-21: a new player in Th17-cell differentiation","volume":"85","author":"Deenick","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cyto.2018.04.026_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00201.x","article-title":"Biology of IL-21 and the IL-21 receptor","volume":"202","author":"Mehta","year":"2004","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2018.04.026_b0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.imbio.2015.09.021","article-title":"Biological effects of IL-21 on different immune cells and its role in autoimmune diseases","volume":"221","author":"Gharibi","year":"2016","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","article-title":"Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barre syndrome","volume":"34","author":"Han","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2018.04.026_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.12174","article-title":"Emerging role of interleukin-33 in autoimmune diseases","volume":"141","author":"Pei","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2018.04.026_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ebiom.2016.06.047","article-title":"The dynamic role of the IL-33\/ST2 axis in chronic viral-infections: alarming and adjuvanting the immune response","volume":"9","author":"Mehraj","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1096\/fj.14-267146","article-title":"Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain","volume":"30","author":"Zarpelon","year":"2016","journal-title":"FASEB J."},{"issue":"18","key":"10.1016\/j.cyto.2018.04.026_b0145","doi-asserted-by":"crossref","first-page":"E2385","DOI":"10.1073\/pnas.1505292112","article-title":"Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs","volume":"112","author":"Fiebiger","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7354","key":"10.1016\/j.cyto.2018.04.026_b0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-017-0818-5","article-title":"Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy","volume":"14","author":"Maddur","year":"2017","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.cyto.2018.04.026_b0160","first-page":"658","article-title":"Pathogenesis of immune-mediated neuropathies","volume":"1852","author":"Dalakas","year":"2015","journal-title":"BBA"},{"issue":"4","key":"10.1016\/j.cyto.2018.04.026_b0165","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.cyto.2018.04.026_b0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain-Barre syndrome","volume":"258","author":"Lu","year":"2011","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.cyto.2018.04.026_b0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/sji.12201","article-title":"Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis","volume":"80","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.04.026_b0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-510X(99)00328-7","article-title":"Immunohistochemical localization of cytokines, C5b\u20139 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome","volume":"174","author":"Putzu","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cyto.2018.04.026_b0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cyto.2017.12.029","article-title":"IL-23\/IL-17 immune axis in Guillain Barre Syndrome: exploring newer vistas for understanding pathobiology and therapeutic implications","volume":"103","author":"Debnath","year":"2018","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2018.04.026_b0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14728222.2016.1086751","article-title":"Are Th17 cells and their cytokines a therapeutic target in Guillain-Barre syndrome?","volume":"20","author":"Wu","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"14","key":"10.1016\/j.cyto.2018.04.026_b0195","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00163-17","article-title":"Selective activation of Type II interferon signaling by Zika Virus NS5 protein","volume":"91","author":"Chaudhary","year":"2017","journal-title":"J. Virol."},{"issue":"2\u20133","key":"10.1016\/j.cyto.2018.04.026_b0200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12026-014-8580-6","article-title":"Intravenous immunoglobulin exerts reciprocal regulation of Th1\/Th17 cells and regulatory T cells in Guillain-Barre syndrome patients","volume":"60","author":"Maddur","year":"2014","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.cyto.2018.04.026_b0205","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/cmi.2014.117","article-title":"Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation","volume":"12","author":"Maddur","year":"2015","journal-title":"Cell. Mol. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:50:55Z","timestamp":1760907055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618301790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":41,"alternative-id":["S1043466618301790"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.026","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barr\u00e9 Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}